Literature DB >> 19674639

Vioxx(R): What should we tell our patients?

Claire Johnson.   

Abstract

In order to provide better care to patients, doctors of chiropractic should be informed about adverse affects of certain drugs. Presently, questions are being raised about cardiovascular risks, such as increased deaths due to stroke or myocardial infarction, which may be caused from drugs in the same class as Vioxx(R).(1) Therefore, it is important for doctors of chiropractic to stay apprised of information that may affect the health of their patients, such as COX-2 inhibitor usage.

Entities:  

Year:  2004        PMID: 19674639      PMCID: PMC2647026          DOI: 10.1016/S0899-3467(07)60104-9

Source DB:  PubMed          Journal:  J Chiropr Med        ISSN: 1556-3707


  8 in total

1.  Failing the public health--rofecoxib, Merck, and the FDA.

Authors:  Eric J Topol
Journal:  N Engl J Med       Date:  2004-10-06       Impact factor: 91.245

2.  COX-2 inhibitor use after Vioxx: careful balance or end of the rope?

Authors:  A Mark Fendrick
Journal:  Am J Manag Care       Date:  2004-11       Impact factor: 2.229

Review 3.  Risk of cardiovascular events associated with selective COX-2 inhibitors.

Authors:  D Mukherjee; S E Nissen; E J Topol
Journal:  JAMA       Date:  2001 Aug 22-29       Impact factor: 56.272

4.  Effectiveness of spinal manipulative therapy in the treatment of mechanical thoracic spine pain: a pilot randomized clinical trial.

Authors:  L Schiller
Journal:  J Manipulative Physiol Ther       Date:  2001 Jul-Aug       Impact factor: 1.437

Review 5.  Supplementation of a home-based exercise programme with a class-based programme for people with osteoarthritis of the knees: a randomised controlled trial and health economic analysis.

Authors:  C J McCarthy; P M Mills; R Pullen; G Richardson; N Hawkins; C R Roberts; A J Silman; J A Oldham
Journal:  Health Technol Assess       Date:  2004-11       Impact factor: 4.014

6.  Acupuncture as a complementary therapy to the pharmacological treatment of osteoarthritis of the knee: randomised controlled trial.

Authors:  Jorge Vas; Camila Méndez; Emilio Perea-Milla; Evelia Vega; María Dolores Panadero; José María León; Miguel Angel Borge; Olga Gaspar; Francisco Sánchez-Rodríguez; Inmaculada Aguilar; Rosario Jurado
Journal:  BMJ       Date:  2004-10-19

7.  Efficacy of preventive spinal manipulation for chronic low-back pain and related disabilities: a preliminary study.

Authors:  Martin Descarreaux; Jean-Sébastien Blouin; Marc Drolet; Stanislas Papadimitriou; Normand Teasdale
Journal:  J Manipulative Physiol Ther       Date:  2004-10       Impact factor: 1.437

Review 8.  Selected CAM therapies for arthritis-related pain: the evidence from systematic reviews.

Authors:  Karen L Soeken
Journal:  Clin J Pain       Date:  2004 Jan-Feb       Impact factor: 3.442

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.